Premier Perspectives The blog for insider insights in clinical development Recent Posts By expertise area All expertise areas Medical DeviceRare DiseaseOncology & HematologyDiagnosticsDigital TherapeuticsMedTechPediatricsNeuroscienceAnalgesiaDermatologyOtherCOVID-19Cell & Gene TherapyWomen's HealthReal-World & Late PhaseLife at Premier By functional area All functional areas Development StrategyClinical Research: Phase 1 - Phase 4ConsultingData Management & BiostatisticsFunctional Service Provider (FSP)Global ComplianceMedical and Regulatory AffairsPatient and Stakeholder EngagementProject ManagementQualityReal-World Science and Late PhaseSafety/PharmacovigilanceStudy DesignStudy Start-UpOtherCOVID-19Product Development Consulting 21st Century Cures Act: Changes to Medical Device Regulation in the U.S. By Premier Research March 13, 2017 Consulting Understanding GCP Basics By Premier Research March 13, 2017 Consulting 5 Endpoints for Rare Oncology Trials By Premier Research March 10, 2017 Consulting 7 Sponsor Responsibilities in Medical Device Clinical Trials By Premier Research March 8, 2017 Consulting European Medical Device Regulations: Coming Changes to the Regulatory Landscape in the EU By Premier Research March 2, 2017 Clinical ResearchPhase 1 - Phase 4 4 Phases of Biomarker Method Validation in Rare Disease Research By Premier Research February 27, 2017 Previous 1 …13 14 15 16 17 18 Next × ALSO OF INTERESTWhen Rare Diseases Take Research Far AfieldProtected: PREMIER VOICES #15: Understanding...The Placebo Problem, Part 15: Ethical Considerations